AC-11® is a federally registered trademark covering a product consisting of an aqueous extract of the botanical Uncaria tomentosa. Applicants have found that administration of AC- 11 ® product in a pharmaceutically effective amount and for a sufficient time period results in enhancement of cognition in people with normal cognition prior to commencing administration. The method of administering the AC-11® product is disclosed and claimed.
A61P 43/00 - Drugs for specific purposes, not provided for in groups
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
2.
METHOD OF ENHANCING COGNITION IN INDIVIDUALS WITH AT LEAST NORMAL COGNITION
AC-11® is a federally registered trademark covering a product consisting of an aqueous extract of the botanical Uncaria tomentosa. Applicants have found that administration of AC- 11 ® product in a pharmaceutically effective amount and for a sufficient time period results in enhancement of cognition in people with normal cognition prior to commencing administration. The method of administering the AC-11® product is disclosed and claimed.
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
3.
Method of enhancing cognition in individuals with at least normal cognition
Uncaria tomentosa. Applicants have found that administration of AC-11® product in a pharmaceutically effective amount and for a sufficient time period results in enhancement of cognition in people with normal cognition prior to commencing administration. The method of administering the AC-11® product is disclosed and claimed.
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
A61K 9/00 - Medicinal preparations characterised by special physical form
UncariaUncariaUncaria tomentosaUncaria tomentosaUncaria tomentosa for a sufficient period of time exhibited an increase in telomere length relative to a baseline measurement taken prior to treatment. The extract may be administered topically or systemically.
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A method of increasing the lengths of telomeres in animal cells is practiced by administering an aqueous extract of an Uncaria species to an animal. The animal may be a human and the Uncaria species may be Uncaria tomentosa. Human subjects receiving a daily dose of an aqueous extract of Uncaria tomentosa for a sufficient period of time exhibited an increase in telomere length relative to a baseline measurement taken prior to treatment. The extract may be administered topically or systemically.
A61P 39/00 - General protective or antinoxious agents
C12N 15/00 - Mutation or genetic engineeringDNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purificationUse of hosts therefor
C12Q 1/6809 - Methods for determination or identification of nucleic acids involving differential detection
Uncaria tomentosa for a sufficient period of time exhibited an increase in telomere length relative to a baseline measurement taken prior to treatment. The extract may be administered topically or systemically.
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
topical skin creams and lotions vitamin supplement, namely botanical extracts of cat's claw
11.
Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals
f=0.2-0.3 band, eluting it in ammonia and freeze drying the eluted band to form a powder; and (v) extracting the powder with methanol to remove solubilized silica gel, concentrating the methanol solution and crystalizing the concentrated solution to obtain the bioactive component. The isolated bioactive component is a quinic acid analog, preferably quinic acid lactone. A pharmaceutical composition comprising a pharmaceutically effective amount of the bioactive component and a nontoxic inert carrier or diluent. The bioactive component may be used to enhance immune competency, treat disorders associated with the immune system, inhibit the inflammatory response, treat disorders associated with the inflammatory response, enhance the anti-tumor response, and treat disorders associated with the response to tumor formation and growth, all in mammals.
A61K 31/34 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
